LucksonMathieuMD

Internal Medicine • Cincinnati, OH

Hematology/Oncology

Physician

Join to view full profile

Dr. Mathieu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mathieu's full profile

Already have an account?

Office
234 Goodman St
Mail Location 0796
Cincinnati, OH 45219
Phone+1 513-584-1000

Education & Training

Johns Hopkins UniversityFellowship, Hematology and Medical Oncology, 2010 - 2013
University of Cincinnati Medical Center/College of MedicineResidency, Internal Medicine, 2006 - 2009
Meharry Medical CollegeClass of 2005

Certifications & Licensure

MD State Medical License 2010 - 2025

Publications & Presentations

PubMed

78 citations
FDA Approval Summary: Atezolizumab and Durvalumab in Combination with Platinum-Based Chemotherapy in Extensive Stage Small Cell Lung Cancer
Luckson Mathieu, Sujay Shah, Lee Pai-Scherf, Erin Larkins, Jonathon Vallejo
The Oncologist. 2021-05-01
47 citations
FDA Benefit‐Risk Assessment of Osimertinib for the Treatment of Metastatic Non‐Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Lauretta Odogwu, Luckson Mathieu, Kirsten B. Goldberg, Gideon M. Blumenthal, Erin Larkins
The Oncologist. 2018-03-01
68 citations
Age and sex differences in the incidence of esophageal adenocarcinoma: results from the Surveillance, Epidemiology, and End Results (SEER) Registry (1973-2008).
Luckson N. Mathieu, Norma Kanarek, Hua-Ling Tsai, Charles M. Rudin, Malcolm V. Brock
Diseases of the Esophagus. 2014-11-01

Press Mentions

FDA Roundup: September 13, 2024September 13th, 2024
Oncologists Discuss ‘Magic Wand’ Solutions to Improve Clinical Trial DiversityMarch 17th, 2024